RELX PLC ORD GBP0.1444
Symbol: REL
Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.
Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.
Invest in this share within an ISA, JISA, SIPP or Investment Account
Charts
Company
Business Summary
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science, advance healthcare and improve performance. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
Financial Summary
BRIEF: For the fiscal year ended 31 December 2024, Relx PLC revenues increased 3% to £9.43B. Net income increased 9% to £1.93B. Revenues reflect Exhibitions segment increase of 11% to £1.24B, Risk & Business information segment increase of 4% to £3.25B, Legal segment increase of 3% to £1.9B, Rest of the World segment increase from £719M to £1.91B, Europe segment increase of 43% to £2.03B, North America segment increase of 3% to £5.5B.
Financials
Income Statement - All values are in GBP (M).
Year Ending |
31/12/2024 |
31/12/2023 |
31/12/2022 |
31/12/2021 |
31/12/2020 |
31/12/2019 |
---|---|---|---|---|---|---|
Total Revenue | 9,434.00 | 9,161.00 | 8,553.00 | 7,244.00 | 7,110.00 | 7,874.00 |
Gross profit | 6,134.00 | 5,945.00 | 5,508.00 | 4,682.00 | 4,623.00 | 5,119.00 |
Operating Profit/Loss | 2,855.00 | 2,610.00 | 2,314.00 | 1,939.00 | 1,655.00 | 2,152.00 |
Profit Before Tax | 2,557.00 | 2,295.00 | 2,113.00 | 1,797.00 | 1,483.00 | 1,847.00 |
Profit After Tax | 1,944.00 | 1,788.00 | 1,632.00 | 1,471.00 | 1,222.00 | 1,515.00 |
Equity Holders of Parent Company | 1,934.00 | 1,781.00 | 1,634.00 | 1,471.00 | 1,224.00 | 1,505.00 |
Minority Interest | 13.00 | -28.00 | -20.00 | -8.00 | 18.00 | 20.00 |
Balance Sheet - All values are in GBP (M).
Year Ending |
31/12/2024 |
31/12/2023 |
31/12/2022 |
31/12/2021 |
31/12/2020 |
31/12/2019 |
---|---|---|---|---|---|---|
Total Non-Current Assets | 12,137.00 | 12,043.00 | 12,760.00 | 11,501.00 | 11,871.00 | 11,344.00 |
Total Current Assets | 2,996.00 | 2,874.00 | 3,069.00 | 2,357.00 | 2,274.00 | 2,445.00 |
Total Assets | 15,133.00 | 14,917.00 | 15,829.00 | 13,858.00 | 14,145.00 | 13,789.00 |
Total Liabilities | 11,629.00 | 11,478.00 | 12,075.00 | 10,634.00 | 12,044.00 | 11,599.00 |
Total Net Assets | 3,504.00 | 3,439.00 | 3,754.00 | 3,224.00 | 2,101.00 | 2,190.00 |
Shareholders Funds | 3,481.00 | 3,460.00 | 3,776.00 | 3,232.00 | 2,099.00 | 2,166.00 |
Minority Interests | 13.00 | -28.00 | -20.00 | -8.00 | 18.00 | 20.00 |
Total Equity | 3,504.00 | 3,439.00 | 3,754.00 | 3,224.00 | 2,101.00 | 2,190.00 |
Outlook
Broker View
Data shown is based on the past 75 days of broker views.
ActionBrokers |
Strong Buy4 |
Buy8 |
Neutral4 |
Sell0 |
Strong Sell0 |
---|---|---|---|---|---|
Brokers | 4 | 8 | 4 | 0 | 0 |
Consensus |
ConsensusBuy |
Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.
Forecasts
Year | 2025 | 2026 | 2027 |
---|---|---|---|
Revenue | £9,972.94mn | £10,694.30mn | £11,313.60mn |
Pre-tax-Profit | £3,390.35mn | £3,669.81mn | £3,913.35mn |
EPS | £1.31p | £1.45p | £1.58p |
EPS Growth | 9.18% | 10.75% | 8.78% |
P/E | 30.47 | 27.51 | 25.28 |
PEG Ratio | 3.32 | 2.56 | 2.88 |
Dividend | 67.34p | 73.30p | 79.43p |
Yield | 0.00% | 0.00% | 0.00% |
Upgrades & Downgrades (Latest)
Date | Broker | Recommendation | Price | Old Target | New Target | Change |
---|---|---|---|---|---|---|
18th Feb 2025 | JP Morgan Cazenove | Reiteration | 4029p | 0p | 4770p | Overweight |
7th Jan 2025 | JP Morgan Cazenove | Reiteration | 3699p | 0p | 4550p | Overweight |
5th Dec 2024 | JP Morgan Cazenove | Reiteration | 3784p | 0p | 4550p | Overweight |
4th Jul 2024 | Citigroup | Reiteration | 3583p | 0p | 0p | Neutral |
16th Feb 2024 | JP Morgan Cazenove | Reiteration | 3402p | 3770p | 4100p | Overweight |
5th Jan 2024 | Berenberg Bank | Reiteration | 3100p | 3270p | 3300p | Buy |
10th Nov 2023 | Berenberg Bank | Reiteration | 2955p | 0p | 3270p | Buy |
3rd Oct 2023 | Barclays | Reiteration | 2760p | 2770p | 2860p | Equal-weight |
27th Sep 2023 | Berenberg Bank | New Coverage | 2741p | 0p | 3270p | Buy |
13th Sep 2023 | JP Morgan Cazenove | Reiteration | 2744p | 3100p | 3170p | Overweight |
Time & Sales
Sorry, sales information on this investment is not available at this time.